Company / Total Assets
MADRIGAL PHARMACEUTICALS, INC. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.3B
FY2025
5-year range
$273.3M / $1.3B
FY2021-FY2025
Trend
+20.9%
vs FY2024
Sector context
#67 of 214
Health Care
What the data says
At $1.3B, MADRIGAL PHARMACEUTICALS, INC.'s total assets ranks #67 of 214 in the Health Care sector. Total Assets has increased for 4 consecutive years, from $273M in FY2021 to $1.3B in FY2025.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of +34.4%.
Improved from $641M to $1.3B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +51.5%
- 5-Year CAGR
- +34.4%
- 10-Year CAGR
- -
Sector benchmark
#67 of 214 in Health CareTop 31% of 214This company $1.3B Sector average $7.5B
▼
-83.1% below sector average
Key checks
Key Insights
- MADRIGAL PHARMACEUTICALS, INC.'s total assets has grown for 4 consecutive years.
- 5-year CAGR of +34.4%, indicating consistent growth.
- In FY2025, total assets increased 20.9% year-over-year.
- Ranks #67 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | +20.9% |
| FY2024 | $1.0B | +62.7% |
| FY2023 | $640.5M | +76.7% |
| FY2022 | $362.6M | +32.6% |
| FY2021 | $273.3M | -4.8% |
| FY2020 | $287.0M | -35.1% |
| FY2019 | $442.1M | -8.9% |
| FY2018 | $485.4M | +152.4% |
| FY2017 | $192.3M | +366.7% |
| FY2016 | $41.2M | -59.1% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026